abl therapyedge
play

ABL TherapyEdge Dr Chalom B Sayada, MD, PhD Administrateur dlgu - PowerPoint PPT Presentation

ABL TherapyEdge Dr Chalom B Sayada, MD, PhD Administrateur dlgu ABL SA IT and Bio Informatics products for optimal personalized healthcare in chronic diseases AREVIR Meeting Cologne, GERMANY May 5th, 2011 Mission &


  1. ABL – TherapyEdge Dr Chalom B Sayada, MD, PhD Administrateur délégué ABL SA IT and Bio ‐ Informatics products for optimal personalized healthcare in chronic diseases AREVIR Meeting Cologne, GERMANY May 5th, 2011

  2. Mission & Current status • ABL is focused on the growing need for informatics ‐ driven physician ‐ centric reporting for complex test results (such as in molecular testing where Siemens is highly involved), to enhance test reporting in all areas of testing, including oncology, genetics, and infectious disease. • More than 25 modules and applications • Active R&D programs in several fields • Current customer base: • Europe, Africa, Asia and recently USA • 150 clinics (Research, Routine) • ~150’000 patients with medical history • ~10’000s of visits per day • >100’000 lab data integrated per day, including HIV/Hepatitis genotyping

  3. ABL-TherapyEdge group

  4. The TherapyEdge platform Optimal Patient Care Personalised Medicine HIS LIS Laboratory Clinical Module Module Online services & Expert Algorithms Knowledge & Standardised Databases (ICD10, ATC), LOINC, EMEA, FDA International & National Guidelines EACS, DHHS, EASL, AASLD

  5. TherapyEdge Box “Turn key” solution to install and  open new site Automated installation & upgrades  Installation time : 40 minutes  Easy configuration over any network  Automated/Regular updates  Operating system  Releases (new functionalities)  Content / Decision support :  Drug/Drug interactions, Resistance algorithms, TherapyEval… 4 Applications & third party online  services: TherapyEdge  ViroScore  DeepChek  FibroMeters 

  6. The solutions – Integration “ All-in-one” patient data repository HIS Advanced & central TE Expert & patient data repository Decision support tools VS ‐ HIV/HBV/HCV TherapyEval LIS VS UDS ‐ HIV/HBV/HCV (Consensus) VS UDS ‐ HIV/HBV/HCV (Amplicons) Data import Third ‐ party services Manual entry VircoType FibroMeters SeqHepB

  7. • TherapyEdge – EHR system – Clinical & Biological database – Multiple knowledge ‐ bases • FibroMeters – Non invasive liver fibrosis analysis • ViroScore – (Sanger sequencing) Data management • DeepChek – (UltraDeepSequencing) Data Management

  8. The solutions – TherapyEdge Key features

  9. The solutions – TherapyEdge From simple to complexe IT structures (1) : Europe and South Africa

  10. The solutions – TherapyEdge From simple to complexe IT structures (2): Botswana PPP (20’000 HIV patients)

  11. The solutions – TherapyEdge Right To Care (NGO in South Africa): HIV PATIENT RETENTION WITHIN SIX MONTHS OF ARV INITIATION at the Themba Lehtu Clinic (Johanesbourg, South Africa) TE hybrid No Clinic charge TE Real Time Quarterly Initiation Period Ref: Evans D., Nagar S., et al., unpublished

  12. The solutions – TherapyEdge TherapyEval module Patient clinical data Knowledge database This patient is on ATZ/R + 3TC + FTC. This patient is on ATZ/R + 3TC + FTC. We can directly see the possible interaction between ATZ and TDF and also We can directly see the possible interaction between ATZ and TDF and also between TDF / FTC between TDF / FTC and trimethoprim (the patient is also on Bactrim). and trimethoprim (the patient is also on Bactrim). TherapyEval gives some recommendation on the dosage of each ARV based on TherapyEval gives some recommendation on the dosage of each ARV based on the weight of the the weight of the patient. patient.

  13. The solutions – ViroScore SUITE Key features

  14. The solutions – ViroScore SUITE Tools & Reports

  15. The solutions – ViroScore SUITE Integration with TherapyEdge Patient summary graph TherapyEval

  16. The solutions – ViroScore SUITE VircoType reports

  17. The solutions – ViroScore SUITE VircoType integration Sequence ViroScore Real ‐ time

  18. Acknowledgements PRIUS project status Towards a GS 454 Junior/DeepChek-HIV clinical genotyping complete solution Max Planck Institute Informatik, Germany IrsiCaixa & Lluita contra la SIDA Fdns, Spain Alexander Thielen Lidia Ruiz, José Ramon Santos & Bonaventura Clotet Roche Diagnostics , S.L., Spain Hospital San Cecilio, Granada, Spain Federico García Artur Palet, Miguel Álvarez ‐ Tejado Therapy Edge, ABL S.A., Luxembourg Hospital 12 de Octubre, Madrid, Spain Rafael Delgado Chalom Sayada, Dimitri Gonzalez Spanish Ministry of Science and Innovation – Mútua de Terrassa, Terrassa, Spain Centro de Desarrollo Tecnológico Industrial (CDTI) David Dalmau, Daniel Irigoyen

  19. UDS HIV Project – Prius Design & groups Design: Observational, multicenter, retrospective cohort study with ~250 HIV patients. Objectives: Estabish a fully integrated database (clinical, biological, UDS), use UDS to increase cost effectiveness of Drug resistance testing Participant centers Laboratorio de Retrovirología irsiCaixa , Badalona, (centro coordinador del estudio), Roger Paredes, Bonaventura Clotet Hospital 12 de Octubre, Madrid, Rafael Delgado Mútua de Terrassa, Terrassa, David Dalmau Hospital Universitario San Cecilio, Granada, Federico Garcia Roche Diagnostics, S.L., España, Artur Palet Therapy Edge, ABL, Luxembourg, Ronan Boulme

  20. The solutions – DeepChek Overview DeepChek report (major population) UDS/DeepChek data Type of report DeepChek report (amplicon by amplicon) (configurable) Detailed DeepChek settings : interpretation ‐ Type of VS ‐ UDS analysis ‐ Template ‐ Cutoff % prevalence ‐ Specific profiles ‐ Resistance analysis options ‐ … Amplicon Prevalenc Subtype Interpretations e AZT LPV DRV 1 12% B STAN R (100%) I (66%) S RIS R (75%) I (100%) S Detailed individual report

  21. The solutions – Roche 454 / DeepChek- HIV/HEP Toward a complete Clinical Genotyping Diagnostic solution ANALYSIS PHASE - Primers Definition - Titanium Plates - Sequencing Protocol PROCESSING PHASE - Processing Protocol - Automated Procedure - Specific Routines AVA-Software - Software Package INTERPRETATION PHASE - Clinical Station Clinical LAB - Software Product Data Tests - Different Levels of analysis - RUO vs IVD ? - Monitoring Patients Basic Analysis - Aids Decision Making Expert Analysis Clonal Analysis Population Analysis (15% / 10% / 5% / 1% …)

  22. UDS HIV Project – Prius Preliminary results

  23. The solutions – Hepatitis modules Overview Fibrosis scoring : Fibrometers Drug resistance : SeqHepB TE viral hepatitis Fibrosis scoring : Fibrometers Drug resistance : SeqHepB TE viral hepatitis BioLiveScale (BLS) Fibrometer Evivar SeqHepB fully integrated fully integrated Manage Hepatitis within TherapyEdge ‐ Viral hepatitis (A, B, C, D, E, F,G) ‐ Alcoholic ‐ Drug ‐ induced… TherapyEval Hepatitis TherapyEval Hepatitis Guidance & alerts dedicated to Hepatitis management. ViroScore viral Hepatitis B & C ViroScore viral Hepatitis B & C

  24. UDS/DeepChek Hepatitis Project – CIBEREHD/Roche/ABL (Spanish Hepatology Clinical and Virological network) Design: Observational, multicenter, retrospective cohort study. Participant centers Vall d’Hebron Institue Recerca (VHIR), Pr. Estaban CiberEHD Roche Diagnostics, S.L., España, Artur Palet TherapyEdge, ABL Spain, Barcelona, Chalom Sayada Hosp.Univ.Vall d’Hebron (HUVH) - Barcelona , Juan Igniacio Estaban & Rafael Esteban Hosp. Clínic. Barcelona, Xavier Forns – Barcelona Hosp. Carlos III. – Madrid , Javier García-Samaniego IPB López Neyra. - Granada , Jordi Gómez Hosp. de la Princesa. - Madrid , Ricardo Moreno Hosp.Univ. De Valme. - Sevilla , Manuel Romero Hosp. San Cecilio. – Granada , Javier Salmeron

  25. UDS Hepatitis Project – Global organization Carlos III Valme Local capturing Web access & recruitment Local capturing & recruitment Data transfer Vall d’Hebron … 454-Junior + Local capturing DeepChek-Hep & recruitment Local capturing & recruitment + inclusion (validation) 25 FibroMeters presentation, May 11th 2011

  26. The solutions – Hepatitis modules The FibroMeter non invasive tests (liver fibrosis) Virtual Biopsy (replace Liver biopsy)  Adapted to the type of Hepatitis   Viral Hepatitis (FibroMeter V) 2G (with hyaluronic acid)   3G (without hyaluronic acid) Alcoholic Hepatitis (FibroMeter A)   Steatosis Hepatitis (FibroMeter S) Cirrhosis   Co ‐ infections (HIV/Hepatitis) Several indicators available  Score + Metavir stage   Inflammation scoring – Inflameter Area of fibrosis  Well validated technology   Compared with competitors (FibroTest…) Approved by the French High Health Authority   Fully integrated in the TherapyEdge platform

  27. The solutions – Hepatitis modules FibroMeter offline ordering & reporting Mail, fax… FibroMeter server central lab… Processing FibroMeter report sent back (mail, fax…) Hepatologist

  28. Value proposition: Explore collaborations with Clinicians, Virologists and Bioinformaticians, for Research and Routine projects, for Commercial and Non ‐ for ‐ profit activities, in the Western and Developing world, in Virology and other chronic diseases Thank You !

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend